. Military Space News .
EPIDEMICS
Scientists make breakthrough in malaria infection study of humans, apes
by Ashley Williams
Washington DC (UPI) Apr 6, 2021

Scientists have solved a century-long puzzle involving malaria parasite infection in people and chimpanzees, a study released Wednesday reveals.

A report published in the peer-reviewed Nature Communications journal explains the origins of the parasite Plasmodium malariae, or P. malariae.

Before evolving to infect humans, experts have discovered that the P. malariae, one of the least well-understood parasites, originates in African apes.

Scientists from the University of Edinburgh in Scotland and the University of Pennsylvania collaborated on analyzing the parasites' DNA to make the breakthrough finding in the National Institutes of Health-funded study.

Researchers say an infection with P. malariae, one of the six species that spreads malaria among humans, is often mild.

However, untreated, it can cause potentially chronic, lifelong infections.

The mystery dates back to the 1920s, when experts discovered chimps infected with parasites that appeared under microscopes to be identical to P. malariae.

Until now, scientists had assumed that both parasites belonged to the same species.

This couldn't be verified in the past because the chimpanzee strain's genetic makeup hadn't before been studied.

DNA analysis has shown that there are three distinct species. P. malariae is the parasitic protozoan that primarily infects humans, while the other two species infect apes.

Central and West Africa-based chimps, gorillas and bonobos were found to be sources of one of the two ape-infecting parasite species that was previously unknown.

The study found that it is only "distantly related" to the human parasite.

Meanwhile, scientists found that the other ape parasite is a closer match to the one that infects people. This knowledge helped researchers more closely compare the two species' diverse genetic makeups.

According to the University of Edinburgh, this finding revealed that the human malaria parasite population went through a genetic bottleneck, causing a temporary shrinking of its population.

Most of the parasite's genetic variation was lost as a result, the research team found.

Scientists assume this occurred because P. malariae started out as an ape parasite, but a small number of parasites switched hosts and began to infect people.

"Our findings could provide vital clues on how it became able to infect people, as well as helping scientists gauge if further jumps of ape parasites into humans are likely," said Edinburgh's Lindsey Plenderleith, lead researcher of the study.

An estimated 241 million malaria cases and 627,000 malaria deaths were reported worldwide in 2020, according to the World Health Organization.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The Space Media Network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceMediaNetwork Contributor
$5 Billed Once


credit card or paypal
SpaceMediaNetwork Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Shares soar in Chinese drugmaker after positive Covid drug trials
Beijing (AFP) April 6, 2022
Shares in the Chinese pharmaceutical group Kintor rocketed on Wednesday after it reported that trials had shown its Covid-19 drug to be highly effective, making it potentially China's first homegrown antiviral treatment. Shares closed up more than 100 percent in Hong Kong after the group said its new pill dramatically reduced the risk of hospitalisation or death from Covid-19, particularly among the middle-aged or elderly. The drug, proxalutamide, cut the risk of hospitalisation or deaths by 50 ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
US approves $95 million sale of missile defense support to Taiwan

Lockheed Martin demonstrates layered missile defense for US Army

MDA and US Army test integration of THAAD and Patriot missile defense

Germany mulling Israeli anti-missile shield purchase

EPIDEMICS
US tests hypersonic missile

Air strikes hit Ukraine's strategic port Odessa

North Korea goes Hollywood with dramatic missile launch footage

UK to send more missiles, money to Ukrainian army

EPIDEMICS
Teal Drones to supply Golden Eagle drone units to NATO Country for deployment in Ukraine

Drones over Ukraine: fears of Russian 'killer robots' have failed to materialise

'Punishment from above': Hobby pilots build Ukraine's drone fleet

DLR measures flow phenomena around wind turbines with a swarm of drones

EPIDEMICS
HENSOLDT Cyber and Beyond Gravity team up for robust satellite cybersecurity

York Space Systems wins 2nd major contract from Space Development Agency

Northrop Grumman and AT&T collaborate to for 5G-enabled defense systems

SpiderOak and Lockheed Martin Space enter space cybersecurity + blockchain collaboration

EPIDEMICS
Biden, Zelensky discuss 'additional capabilities' for Ukraine military

Ukraine demands unlimited NATO aid against Russia's month-old war

Kyiv urges West to supply offensive weapons to fight Russia

Javelin anti-tank missile, symbol of Ukraine's resistance

EPIDEMICS
Poland orders US tanks, other battle vehicles for $4.74 bn

Finland boosts defence spending by 2 bn euros over Ukraine

US defense contractors see longer term benefits from war in Ukraine

Ukraine war spurring NATO allies to spend more: Stoltenberg

EPIDEMICS
US wants bases in E. Europe, but for short-term deployments: general

Chinese, Ukrainian foreign ministers discuss Russia invasion

More Ukrainians move west as Russia turns focus to Donbas

Czechs send 250 soldiers to Slovakia to set up NATO battlegroup

EPIDEMICS
Atom by atom: building precise smaller nanoparticles with templates

Ring my string: Building silicon nano-strings

Nanotube films open up new prospects for electronics

Using the universe's coldest material to measure the world's tiniest magnetic fields









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.